UK wound care firm seals £2m new money
This article was originally published in Clinica
Advanced wound care therapy developer Wound Solutions has raised £2m ($2.9m) in the first tranche of a series A financing round. Contributors of this new capital were not disclosed. The funds will enable the firm to advance its ongoing clinical study to an interim review stage. London, UK-based Wound Solutions is developing a series of electrotherapy devices for treating chronic wounds. Its first product will focus on venous leg ulcers. The company plans to raise a further £6m in the round to complete the clinical study and take its product through regulatory approval.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.